Inside Forbion’s M&A-First Playbook for Building Europe’s Biotech Winners

Nann Luneborg and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to explain Forbion’s blueprint for success in Europe’s maturing biotech ecosystem.